Clinical Significance of Antinuclear Antibody Results in Patients with Uveitis
Journal of the Korean Ophthalmological Society · 15.04.2026 · 67 (4) · 110-117
DOI: 10.3341/jkos.2026.67.4.110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Korean Ophthalmological Society, erschienen am 15.04.2026. Verfasst von Do-Hyeon An und 3 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
This study investigated the results of antinuclear antibody (ANA) testing in Korean patients with uveitis, examining its relationship with the clinical course of uveitis and systemic diseases.
Methods
We conducted a retrospective analysis of the medical records of 64 patients with noninfectious uveitis who underwent ANA testing and were followed for at least 6 months at the Department of Ophthalmology at Seoul St. Mary's Hospital from January 2006 to December 2021. Patients were divided into ANA-positive and ANA-negative groups and correlations between uveitis-related factors and ANA status were assessed.
Results
Among the 516 patients tested for ANA, 6.58% (34/516) were positive. The initial visual acuity (logMAR) before treatment was significantly better in the ANA-positive group (0.21 ± 0.20) than in the ANA-negative group (0.59 ± 0.68) (p = 0.002). However, the final visual acuity after treatment showed no statistically significant difference between the two groups. Additionally, no statistically significant differences were observed in terms of immune deficiency status, types of associated rheumatic disease, rheumatoid factor positivity, erythrocyte sedimentation rate, C-reactive protein (define) levels, or treatment modalities. No significant correlation was found between ANA titers and the severity of uveitis.
Conclusions
Relationships between ANA positivity and the etiology, treatment outcomes, and systemic diseases associated with uveitis are unclear. Routine ANA testing is not recommended for the diagnosis of uveitis.
Zitieren
APA
An, D., Suh, H., Park, Y., & Kim, M. (2026). Clinical Significance of Antinuclear Antibody Results in Patients with Uveitis. Journal of the Korean Ophthalmological Society, 67(4), 110-117. https://doi.org/10.3341/jkos.2026.67.4.110
Vancouver
An D, Suh H, Park Y, Kim M. Clinical Significance of Antinuclear Antibody Results in Patients with Uveitis. Journal of the Korean Ophthalmological Society. 2026;67(4):110-117. doi:10.3341/jkos.2026.67.4.110
BibTeX
@article{An2026,
author = {An, Do-Hyeon and Suh, Hyun and Park, Young-Hoon and Kim, Mirinae},
title = {Clinical Significance of Antinuclear Antibody Results in Patients with Uveitis},
journal = {Journal of the Korean Ophthalmological Society},
year = {2026},
volume = {67},
number = {4},
pages = {110--117},
doi = {10.3341/jkos.2026.67.4.110}
}
EUVIMED